SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-09-025132
Filing Date
2009-05-08
Accepted
2009-05-08 17:29:12
Documents
4
Period of Report
2009-06-18

Document Format Files

Seq Description Document Type Size
1 v148535_pre14a.htm PRE 14A 2780637
2 GRAPHIC logo.jpg GRAPHIC 6130
3 GRAPHIC v148535_proxycardx1x1.jpg GRAPHIC 351827
4 GRAPHIC v148535_proxycardx2x1.jpg GRAPHIC 253265
  Complete submission text file 0001144204-09-025132.txt   3624809
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-51531 | Film No.: 09812035
SIC: 2834 Pharmaceutical Preparations